A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
about
Insomnia pharmacotherapyNoise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplonZolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscopePhase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonistThe orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomniaZaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects.Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.Treatment of insomnia in hospitalized patients.Safety of zaleplon in the treatment of insomnia.Use of non-benzodiazepine sedative hypnotics and risk of falls in older men.Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case seriesThe Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of ZaleplonAcute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use.Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.Therapeutic options for sleep-maintenance and sleep-onset insomnia.Clinical evaluation of zaleplon in the treatment of insomnia.Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakeningsThe effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidationA new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.Evaluation of a new computerized psychometric test battery: Effects of zolpidem and caffeine.Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task.Medications for Sleep Schedule Adjustments in Athletes.The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine.Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition.Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia.Critical flicker frequency for quantification of low-grade hepatic encephalopathy.
P2860
Q24623757-D69BE5EC-F343-40E4-9A34-FD4B84D6BFACQ24682992-20ED6BBA-45FF-4309-BB00-BA8A684C3B9BQ27331440-9B75EE49-9F8F-4620-80B6-CA98308CB068Q28242421-F6E755C6-4392-4E41-9269-A61D807B8448Q28272266-D2C635AD-9AA8-4049-B394-0255EB40BA5DQ31521391-60AB0BE5-4D8A-4900-AF48-CEC303D56DE9Q33156940-C6187237-B91B-4298-A130-B5AA9BB9D49BQ34156627-22FD34FC-3875-4FC8-8CCE-DB4D720582C1Q34449459-B3449812-98C1-4164-991C-C1CFDA95A292Q34615602-8C9961D7-BABE-488F-B7E9-9019E4059EA4Q34901793-D4E969D7-9D65-4D96-B896-B8E1DF05728FQ35583074-5E3D69D9-536E-4140-A981-8C9BF8C5AF66Q35665983-E30B5CB6-6599-4682-8A92-B0CC17116DC5Q35760992-F85A5FC0-D4A3-44C1-A415-DD7B1AC4810FQ36511609-2E8EA168-5827-46CA-9B39-1FBA111EFF5EQ36693857-E6B26E9F-8E06-449B-8A54-0839927476ABQ36779803-C9B5B511-1763-4654-B659-B5CF71B31281Q36891199-F35E506B-349F-405D-B6DA-CF0B13528778Q37405829-31193C6C-5574-4D4E-8E69-CC5EE5BDA36BQ37979871-48633D09-9C7B-4B96-B435-C22FB233473FQ38220445-E1372EEC-CDE3-4E25-94D0-6C1F4B4467D1Q42909915-02DD98AE-0BF1-41E1-9344-8B966D0BCAFBQ44511458-D30B8A29-26EE-476E-AB30-AD0905FD4BB9Q44931603-7E26CC6F-0D09-40A2-A9DA-AF1FD4365A30Q47435627-9BA4608D-AE39-43C5-807D-B630C640FB9DQ47738084-4B922D2E-6CAB-40DD-8AE6-FAAE73F34B25Q48020552-C6C6F7AA-95E9-422A-8E6E-CE4D5661709CQ48647100-BFEA01D5-9ECF-45B3-AB66-DC555F9DA49AQ51960052-567229F9-856B-46A8-87E8-8EF42346D691
P2860
A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
A comparison of the residual e ...... ion 5 to 2 h before awakening.
@ast
A comparison of the residual e ...... ion 5 to 2 h before awakening.
@en
type
label
A comparison of the residual e ...... ion 5 to 2 h before awakening.
@ast
A comparison of the residual e ...... ion 5 to 2 h before awakening.
@en
prefLabel
A comparison of the residual e ...... ion 5 to 2 h before awakening.
@ast
A comparison of the residual e ...... ion 5 to 2 h before awakening.
@en
P2093
P2860
P1476
A comparison of the residual e ...... ion 5 to 2 h before awakening.
@en
P2093
P Worthington
R Fruncillo
W Cevallos
P2860
P304
P356
10.1046/J.1365-2125.1999.00024.X
P407
P577
1999-09-01T00:00:00Z